ARIAD Pharmaceuticals' P2P Acquisition

ARIAD Pharmaceuticals raised a round of funding on February 17, 2017. Investors include Takeda Pharmaceutical.

ARIAD is developing breakthrough medicines that regulate cell-signaling pathways implicated in cancer. Our pipeline includes a series of small molecule product candidates that provide targeted and hig…

Articles about ARIAD Pharmaceuticals' P2P Acquisition: